Japan Agency for Medical Research and Development
Tokyoamed.go.jp
Overview
A Japanese government funding agency established in 2015 to promote integrated medical research and development, from basic research to practical applications. It aims to accelerate the translation of research into healthcare solutions by consolidating R&D budgets from multiple ministries and providing streamlined support for projects in areas like regenerative medicine, rare diseases, infectious diseases, and oncology.
Portfolio Companies
24
Website
amed.go.jpInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| TAGCyx Biotechnologies Inc. | Apr 2026 | Grant | Co-investor |
| United Immunity, Co., Ltd. | Feb 2026 | Grant | Co-investor |
| EVA Therapeutics, Inc. | Jan 2026 | Grant | Co-investor |
| EVA Therapeutics, Inc. | Jan 2026 | Grant | Co-investor |
| Senno Therapeutics Inc. | Jan 2026 | Grant | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
